Tunnel Formation in Hidradenitis Suppurativa
When sinus tracts extend and connect — forming an interconnected network of channels beneath the skin — HS has entered its most structurally complex stage. Tunnels are not a different disease; they are the architectural consequence of sustained inflammatory activity across multiple recurrence cycles. Understanding what drives tunnel formation — and what treatment must address — is the foundation for managing HS at this stage.
What Tunnel Formation Actually Means — Clinically and Structurally
AyurvedaSrotorodha · Nadi VranaThe transition from individual sinus tracts to a tunnel network represents a qualitative change in disease architecture. Understanding what has occurred structurally — and why — provides the context for understanding both surgical and non-surgical aspects of management.
A Network of Connected Sub-Dermal Channels
A tunnel in HS is an interconnected system of epithelialised channels running through the dermis and subcutaneous tissue, connecting multiple follicular involvement sites and often having several external openings. Unlike a single sinus tract, a tunnel network has a branching, three-dimensional structure that cannot be fully appreciated from the surface. The full extent of tunnel involvement is often larger than it appears externally — a fact that has significant implications for surgical planning and for understanding why excision margins sometimes fail to include all involved tissue.
Extension and Coalescence of Individual Tracts
Tunnels form when the inflammatory process that created individual sinus tracts continues to be active — eroding the tissue between adjacent tracts and causing them to merge. This extension occurs because the internal driver has not been interrupted. Each additional inflammatory cycle contributes to the progressive destruction of the tissue barriers between tracts, allowing them to coalesce into a network. This progression is not sudden: it occurs over months to years of sustained internal inflammatory activity without adequate correction.
The Same Internal Driver — More Time, More Damage
The biological driver of tunnel formation is identical to the driver of early-stage HS: sustained internal inflammation — from the gut, hormonal system, and immune dysregulation — that continuously creates the conditions for follicular damage, abscess formation, and sinus tract development. What distinguishes tunnel-stage HS is not a different pathology but the same pathology operating over a longer period, accumulating more structural damage. This is why correcting the internal driver remains relevant even at this advanced stage — it prevents further extension even if it cannot reverse established architecture.
Removing Tunnels ≠ Stopping the Disease
Wide local excision of tunnel networks removes the existing structural damage — and this is clinically meaningful. However, surgery does not address the internal inflammatory driver that generated the tunnels. In patients who undergo excision without internal correction, new lesion formation in adjacent tissue — or at other body sites — continues because the internal environment remains unchanged. The recurrence rate after surgery alone in HS is significant and well documented. This is why surgical management is most durable when the internal driver is simultaneously addressed.
The Progression From First Boil to Established Tunnel Network
Tunnel formation is the end point of a clearly traceable progression. Understanding each stage in that progression — and identifying where in it internal correction has the most impact — provides a realistic framework for treatment at any stage of the disease.
Repeated Follicular Inflammation — The Starting Point
Every tunnel begins with repeated inflammatory episodes at a follicular site — the same boil-and-recurrence cycle characteristic of early HS. Each episode partially destroys the surrounding tissue. Without adequate healing between episodes — prevented by the continued internal inflammatory state — cumulative tissue destruction accumulates at the site. This process may occur over months or years before any structural channel has fully formed.
Sinus Tract Formation — The Intermediate Stage
As the accumulated tissue destruction at a recurrence site creates a consistent pathway, the body epithelialises it — forming the first sinus tract. This tract becomes an outlet for ongoing inflammatory material: the draining sinus phase. At this stage, the tissue destruction is primarily vertical (into the dermis) and localised to one area. The internal driver is still the same, but the structural consequence has now become a persistent channel rather than episodic lesions.
Lateral Extension — Tracts Begin to Reach Each Other
As the internal inflammatory driver continues to be active, new follicular sites adjacent to existing tracts become involved. Simultaneously, the inflammatory process within established tracts erodes the tissue laterally, extending the tract toward adjacent sites of involvement. This is where individual sinus tracts begin the process of interconnection. The extension is driven by the same inflammatory mediators sustaining the original tract — progressing through the path of least structural resistance in the chronically inflamed tissue.
Coalescence — The Tunnel Network Establishes
When extending tracts breach the tissue barriers between them, they merge — creating the branching, interconnected network that constitutes an established tunnel. Multiple external openings may develop as the network reaches the surface at several points. The tunnel at this stage has a three-dimensional architecture that extends beyond what is visible or palpable externally. The internal driver is still active — feeding ongoing inflammation within the network and sustaining new lesion formation at its margins.
Fibrosis and Scarring — Tissue Remodelling
Alongside the active inflammatory channels, the surrounding tissue undergoes fibrotic remodelling — the body's attempt to stabilise an area of chronic destruction. This fibrosis is not neutral: it can tether the overlying skin, restrict movement, and make the area progressively more difficult to manage — both clinically and surgically. The degree of fibrosis reflects the cumulative duration and intensity of inflammatory activity at the site. Reducing internal inflammation progressively slows further fibrotic deposition even in established disease.
A tunnel network is not a separate disease — it is the architectural record of what internal inflammation has done to the tissue over time. The process that built it is the same process that will extend it, unless the internal driver changes.
Surgery and Internal Correction — What Each Does and Why Both Matter
At the tunnel-formation stage, both surgical and internal approaches are often relevant. Understanding what each addresses — and what each cannot do alone — helps clarify why they work best in combination rather than as alternatives.
Surgical Management
Wide Local Excision — What It Addresses
Internal Correction
Root-Cause Approach — What It Addresses
The Internal Systems Sustaining Tunnel Activity
Even at the tunnel stage, the same internal systems that initiated HS are still active — still driving new inflammatory episodes, extending existing tunnel margins, and creating the conditions for new involvement sites. These are the targets of internal correction.
Dysregulated Immune Architecture Within the Tunnel
Established tunnels contain a complex immune environment — chronic immune infiltrate, biofilm-associated bacterial signalling, and continuous cytokine production. The immune system at these sites is locked in a chronic activation state that perpetuates tissue damage and resists resolution. Recalibrating this immune environment — through systemic correction of the driver that initiated the dysregulation — progressively reduces inflammatory activity within the tunnel, even if it cannot reverse the structural channel itself.
Ongoing Follicular Susceptibility at Tunnel Margins
The follicular tissue at the margins of existing tunnel networks remains susceptible to new inflammatory episodes — particularly when the hormonal and metabolic drivers that created that susceptibility are still active. New lesion formation at tunnel margins extends the network and complicates both management and potential surgical planning. Hormonal and metabolic correction directly reduces this ongoing follicular vulnerability, limiting the further extension that would otherwise occur.
Systemic Inflammatory Amplification
Gut dysbiosis continuously feeds the systemic inflammatory state that sustains active tunnel involvement. Patients with established tunnel-stage HS often show markers of elevated systemic inflammation that extend beyond the local disease. Gut restoration reduces this systemic amplification — lowering the overall inflammatory burden that the immune system at tunnel sites is responding to. In many patients, gut-directed treatment produces observable reductions in drainage activity and pain even before any change in tunnel architecture is expected.
A Structured Approach to Tunnel-Stage HS — Realistic and Meaningful Goals
Treatment at this stage operates on two levels simultaneously: reducing the internal driver's ongoing activity, and creating conditions where the existing structural damage can be managed most effectively — whether through continued internal work or in combination with surgical approaches.
What Changes With Internal Correction
The most immediate clinical gains from internal correction at the tunnel stage are functional: reduction in drainage volume, improvement in pain levels, reduction in the frequency of acute flares within existing tunnel networks. These changes reflect a reduction in the inflammatory activity sustaining the tunnel — not structural closure, but meaningful improvement in the daily experience of the condition.
Over time, with sustained internal correction, many patients observe stabilisation of their disease — fewer new lesion sites, slower extension of existing tunnel margins, and in some cases, reduction of drainage from previously active tracts as the internal environment becomes less hostile to tissue quiescence.
When surgical intervention is planned or underway, internal correction directly improves outcomes. A less inflamed tissue environment at the time of surgery heals more reliably; the reduced internal driver after surgery reduces the speed of new lesion formation at adjacent sites.
The goal is not to choose between surgery and internal correction — it is to understand that surgery addresses what has already happened, while internal correction addresses what will happen next. Both are part of a complete approach to tunnel-stage HS.
Lowering Inflammatory Load — Systemic detoxification and gut restoration to reduce the inflammatory amplification sustaining tunnel activity
Internal Healing — Targeted formulations that reduce immune activation within and around tunnel margins, progressively limiting active drainage
Functional Detox — Clearing the metabolic and inflammatory load that sustains the systemic environment feeding tunnel activity
External Care — Local management protocols that maintain hygiene, reduce secondary infection risk, and support tissue stability at active sites
Sustaining Stability — Long-term systemic correction to prevent new lesion formation and support the durability of any surgical outcomes achieved
Understanding Where Tunnel Formation Fits in the HS Progression
Tunnel Formation Is Advanced — But the Internal Driver Is Still Correctable
A personalised evaluation assesses what internal systems are sustaining your tunnel-stage HS — and establishes a structured approach that reduces ongoing inflammatory activity, prevents further extension, and supports any surgical management in achieving more durable outcomes.